China portfolio company Gushengtang lists on HKEX
Traditional Chinese medicine healthcare service provider Gushengtang goes public in Hong Kong.

As an early investor, Eight Roads Ventures China led its Series B round in 2015 and continued to participate in the following rounds. 

Share price gained more than 15% on the first day of trading, with a market cap over HK$7bn. The funds raised will mainly be used to Further broaden medical resource coverage, deepen the integration of offline and online healthcare platforms and increase market penetration.

 

null
null
null
Share